Skip to content

Good Life Plus PLC - Grant of Options and PDMR


Announcement provided by

Good Life Plus Plc · GDLF

04/03/2024 07:45

Good Life Plus PLC - Grant of Options and PDMR
RNS Number : 3644F
Good Life Plus PLC
04 March 2024
 

For release at 07.45: 4 March 2024

 

Good Life Plus Plc

(the "Company" or "Good Life Plus")

Grant of Options and PDMR

Good Life Plus Plc (AQSE: GDLF), an innovator in the luxury prize draw and rewards sector, is pleased to announce the grant of options over 38,142,199 Ordinary Shares of £0.001 each in the Company (the "Options") to certain directors, PDMRs, company advisors and other members of staff.  The Company announced its intent to issue the majority of these options in its Admission Document dated 30 November 2023.  A number of further options, not outlined in the Admission Document, have been granted to new employees and to the recently appointed Chairman, David Craven.

Included in the above total are options over 30,715,088 Ordinary Shares which were granted to Directors and PDMRs, as set out below:


Status

Exercise price (£)

Options granted

Current shareholding in Company

Charlie Chadd

Director

0.0225

11,111,111

191,611,489

Joe Chadd

Director

0.0225

7,407,422

127,740,993

David Ivy

PDMR

0.0225

3,111,111

0

Iain McCaid

PDMR

0.0225

1,777,778

0

Ben Smith

PDMR

0.0225

1,333,333

0

John Gordon

Director

0.0225

1,066,667

0

John Taylor

Director

0.0225

750,000

0

David Craven

Director

0.0225

4,193,666*

0

Total

 

 

30,715,088

319,352,482

 

*The Company has also committed to issuing two further batches of 4,193,666 options to David Craven on the 12 month and 24 month anniversary of his appointment with exercise prices reflecting the prevailing share price at the time of grant.

 

Following the grant of the Options, the Company has 38,142,199 Ordinary Shares under option, representing 5.3% of the total issued share capital of the Company following the issue of the Subscription Shares announced earlier today.

This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended). 

The Directors of the Company take responsibility for this announcement.

-Ends-

For further information please contact:

Good Life Plus Plc                                                                                                                                +44 (0)7500 929157

Charlie Chadd, Chief Executive

 

Novum Securities Limited

AQSE Corporate Advisor

David Coffman / Daniel Harris / George Duxberry                                                                    +44 (0)20 7399 9400

 

Belvedere Communications Limited

Financial Media and Investor Communications

John West / Lily Pearce                                                                                                                  + 44 (0)20 7653 8702

goodlifeplus@belvederepr.com

 

Notification and public disclosure of transaction by person discharging managerial responsibilities

 

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name


1)    Charlie Chadd

2)    Joe Chadd

3)    David Ivy

4)    Iain McCaid

5)    Ben Smith

6)    John Gordon

7)    John Taylor

8)    David Craven

2

Reason for notification

 

 


a.

Position/Status


1)    Director

2)    Director

3)    PDMR

4)    PDMR

5)    PDMR

6)    Director

7)    Director

8)    Director

b.

Initial notification/

Amendment


Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name


Good Life Plus Plc

b.

LEI


2138003B288DJIG8LQ90

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrument
Identification Code




Options over Ordinary shares of £0.001 each

ISIN Code: GB00BPSMPW93

b.

Nature of the transaction


Grant of Options

c.

Price(s) and volume(s)


1) £0.0225

11,111,111

2) £0.0225

7,407,422

3) £0.0225

3,111,111

4) £0.0225

1,777,778

5) £0.0225

1,333,333

6) £0.0225

1,066,667

7) £0.0225

750,000

8) £0.0225

4,193,666

d.

Aggregated information

 

- Aggregated Volume

 

- Price


 

 

30,715,088 Ordinary Shares

 

£0.0225

e.

Date of the transaction


4 March 2024

f.

Place of the transaction


Outside of a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXSSWFMDELSEDD]]>

View more ...

GDLF announcementsAll announcements

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers
ISO 27001 Certified

© Aquis Exchange 2024. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal